Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04460664 · ClinicalTrials.gov registry record

Coagulation Changes Associated With COVID-19 Infection

A clinical trial, sponsored by HemoSonics.

Completed
Registry status
15
Enrollment target

NCT04460664 is a clinical trial that has completed, run by HemoSonics. The registered enrollment target is 15 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04460664 has completed, sponsored by HemoSonics.

COMPLETED
Registry status
15 participants
Enrollment target

Study Summary

This study will study the potential utility of the Quantra QPlus System in patients inflicted with COVID-19 disease.

Interventions

  • DIAGNOSTIC_TEST Quantra System

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2020-08-14
Est. Completion 2022-01-26

Sponsor

HemoSonics

24 total trials

What the Registry Record Tells You About NCT04460664

The ClinicalTrials.gov registry entry for NCT04460664 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HemoSonics, which has 24 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Quantra System is the first listed.

NCT04460664 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04460664 about?

NCT04460664 is a clinical study titled "Coagulation Changes Associated With COVID-19 Infection". This study will study the potential utility of the Quantra QPlus System in patients inflicted with COVID-19 disease.

What is the current status of trial NCT04460664?

This trial is currently completed. The enrollment target is 15 participants. The study started on 2020-08-14. Estimated completion is 2022-01-26.

What interventions are being tested in trial NCT04460664?

The interventions under investigation include: Quantra System (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04460664?

This trial is sponsored by HemoSonics, which has 24 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.